Best Medical Oncology specialists in MassachusettsPage 2

Match with a top Medical Oncology specialist in Massachusetts — priority appointment in days, not months.

Medical Oncology · Massachusetts

Jennifer Ligibel, MD

Professor at Harvard Medical School and a Senior Physician in the Breast Oncology Center at the Dana-Farber Cancer Institute. Dr. Ligibel’s research focuses on; Director of the Leonard P. Zakim Center for Integrative Therapies and Healthy Living and has built a comprehensive clinical Healthy Living Program for patient

Oncology

Boston, MA

Bruce Johnson, MD

Professor Emeritus of Medicine, Harvard Medical School; Institute Physician, Dana-Farber Cancer Institute

Oncology

Boston, MA

Ann Partridge, MD MPH

Chief Clinical Strategy Officer, Vice Chair of Medical Oncology, and founder and director of Young and Strong, the Program for Young Adults with Breast Can; Chair in Breast Cancer Research at Dana-Farber. She conducts clinical research focused on improving cancer care and outcomes with a particular focus on you

Oncology

Boston, MA

Jeremy Abramson, MD

Director of the Lymphoma Program and the Jon and Jo Ann Hagler Chair in Lymphoma, Massachusetts General Hospital Cancer Center; Associate Professor of Medicine, Harvard Medical School

Oncology

Boston, MA

Elizabeth Buchbinder, M.D.

Assistant Professor of Medicine, Harvard Medical School

Oncology

Boston, MA

Thomas Spitzer, MD

Professor of Medicine, Harvard Medical School; Director, Bone Marrow Transplant Program, Massachusetts General Hospital

Oncology

Boston, MA

Filipa Lynce, M.D.

Assistant Professor of Medicine, Harvard Medical School; Associate Director, Inflammatory Breast Cancer Program, Dana-Farber Cancer Institute

Oncology

Boston, MA

Jeffrey Meyerhardt, MD MPH

Chief Clinical Research Officer; Director, Colon and Rectal Cancer Center

Oncology

Milford, MA

Ann Silk, M.D.

Director of the Merkel Cell Carcinoma Center of Excellence; Assistant Professor of Medicine, Harvard Medical School

Oncology

Boston, MA

George Demetri, MD

Professor of Medicine, Harvard Medical School; Director, Sarcoma Center, Dana-Farber Cancer Institute; Senior Vice President for Experimental Therapeutics, Dana-Farber Cancer Institute; Co-Director, Ludwig Center at Dana-Farber/Harvard

Oncology

Boston, MA

David Kuter, MD DPHIL

Director of Clinical Hematology at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School

Oncology

Boston, MA

Leif Ellisen, MD PHD

Professor of Medicine, Harvard Medical School; Program Director, Breast Medical Oncology, Mass General Cancer Center

Oncology

Boston, MA

Michael Hassett, M.D., M.P.H.

Chief Resident in Internal Medicine at the University of Rochester in Rochester, NY, he went on to complete a fellowship in Medical Oncology at Dana-Farber

Oncology

Boston, MA

Nikhil Munshi, MD

Professor of Medicine, Department of Medicine, Harvard Medical School; Director of Basic and Correlative Science, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute

Oncology

Boston, MA

Irene Ghobrial, M.D.

Senior Vice President for Experimental Medicine, Director of the Center for Early Detection and Interception of Blood Cancers, Co-Leader of the Lymphoma/Myeloma Cancer Center Program, Lavine Family Chair for Preventative Cancer Therapies, Director of the Ghobrial Lab, and Professor of Medicine at Dana-Farber Cancer Institute and Harvard Medical School

Oncology

Boston, MA

Brian Wolpin, M.D.

Director, Gastrointestinal Cancer Center; Director, Hale Family Center for Pancreatic Cancer Research

Oncology

Boston, MA

Peter Enzinger, MD

Director, Center for Esophageal and Gastric Cancer; Associate Professor of Medicine, Harvard Medical School; Institute Physician

Oncology

Boston, MA

Lori Wirth, MD

Elizabeth and Michael Ruane Endowed Chair of Medical Oncology; Medical Director, Center for Head and Neck Cancers; Associate Professor of Medicine, Harvard Medical School

Oncology

Boston, MA

Michael Constantine, M.D.

Director, Medical Oncology, Dana-Farber Brigham Cancer Center at Milford Regional Medical Center

Oncology

Boston, MA

Ana Garrido-Castro, M.D.

Assistant Professor of Medicine; Director, Triple-Negative Breast Cancer Research, Division of Breast Oncology

Oncology

Boston, MA

Frequently Asked Questions

What does a Medical Oncology oncologist do?

A Medical Oncology oncologist is a Oncology physician with focused training in the systemic treatment of cancer with chemotherapy, targeted therapy, immunotherapy, and hormonal therapy. After completing Oncology residency, they pursue additional fellowship training so they can manage cases that fall outside what a general oncologist typically handles day to day.

What conditions does a Medical Oncology oncologist treat?

A Medical Oncology oncologist commonly treats breast cancer, colorectal cancer, lung cancer, lymphomas, melanoma, and pancreatic cancer. Many also see closely related conditions within Oncology, particularly when a case is complex, atypical, or has not responded to first-line care from a general oncologist.

When should I see a Medical Oncology oncologist?

Consider seeing a Medical Oncology oncologist when you have a new cancer diagnosis or your treatment plan involves systemic therapy, when a primary care clinician or general oncologist suggests a focused evaluation, or when you want a second opinion from a physician whose practice is concentrated on this exact area. Patients often reach a Medical Oncology oncologist through referral, but you can also seek one directly.

How is a Medical Oncology oncologist different from a general oncologist?

Both are board-eligible oncologists, but a Medical Oncology oncologist has additional fellowship training and a practice that focuses on the systemic treatment of cancer with chemotherapy, targeted therapy, immunotherapy, and hormonal therapy. General oncologists treat a broad range of Oncology concerns; Medical Oncology oncologists concentrate on the harder or more specific cases within that range, and tend to see a higher volume of patients with breast cancer, colorectal cancer, lung cancer, lymphomas, melanoma, and pancreatic cancer.

How does Convene match me with a top Medical Oncology oncologist?

Convene Health evaluates oncologists on peer recognition, clinical leadership, published research, institutional affiliations, and patient feedback. When you complete an intake, our care team reviews your history and matches you with a vetted Medical Oncology oncologist whose focus aligns with your case. Membership covers priority appointment coordination; the match itself is free.

← Back to Oncology in Massachusetts